T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus

(NZB x NZW) F1 (BWF1) mice develop spontaneous T cell autoimmunity to VH region determinants of syngeneic anti-DNA before the onset of clinical disease. In this study, we characterized the immunogenicity, MHC binding, and lymphokine secretion patterns induced by T cell determinants from the VH region of one such anti-DNA mAb (A6.1) and examined their role in the regulation of autoimmunity. Determinants were identified by proliferation of syngeneic splenic T cells from young, unprimed BWF1 mice in response to overlapping 12-mer peptides representing the entire VH region sequence. Immunization of young BWF1 mice with any of three determinants (A6H 34-45 [p34], A6H 58-69 [p58], and A6H 84-95 [p84]) elicited proliferative responses upon in vitro recall. Upon immunization with the whole A6.1 molecule, however, proliferative responses could be recalled only to the p58 peptide, defining this as immunodominant. The other two peptides (p34 and p84) elicited minimal or no proliferation and could be termed cryptic. Proliferative responses elicited by the cryptic determinants were restricted by a single class II (I-Ed for p34 and I-Au for p84), whereas the immunodominant p58 determinant was restricted by both I-Ed and I-Eu. The cryptic p34 and p84 bound strongly to I-Ed and I-Au, respectively, whereas the immunodominant p58 peptide bound poorly to I- Ed. A6H p84 elicited T cells that secreted lymphokines in a pattern consistent with a Th1-like phenotype, whereas p58 induced a Th2-like cytokine pattern. Immunization with p34 or p84, or adoptive transfer of a p84-reactive T cell line to young BWF1 mice significantly increased IgG anti-DNA levels, accelerated nephritis, and decreased survival. In conclusion, in BWF1 mice, autoreactive T cells recognizing both cryptic and dominant self-determinants on anti-DNA autoantibodies escape deletion or anergy induction. Furthermore, since these cells are spontaneously activated before the onset of clinical disease, they may be involved in the development of the autoimmune process.

[1]  R. Coffman,et al.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.

[2]  B. Tsao,et al.  Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. , 1994, International immunology.

[3]  H. Mcdevitt,et al.  A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. , 1994, Immunity.

[4]  M. Howard,et al.  Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice , 1994, The Journal of experimental medicine.

[5]  M. Takei,et al.  Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4. , 1993, Journal of Immunology.

[6]  E. Sercarz,et al.  Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. , 1993, Journal of immunology.

[7]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[8]  R. Coffman,et al.  Cytokine regulation of T-cell function: potential for therapeutic intervention. , 1993, Trends in pharmacological sciences.

[9]  C. Mohan,et al.  Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus , 1993, The Journal of experimental medicine.

[10]  M. Gershwin,et al.  Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice. , 1993, Journal of immunology.

[11]  E. Sercarz,et al.  A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus. , 1993, Arthritis and rheumatism.

[12]  D. McCarthy,et al.  Mixed haplotypes and autoimmunity. , 1993, Immunology today.

[13]  S. Weiss,et al.  Processing and presentation of idiotypes to MHC-restricted T cells. , 1993, International reviews of immunology.

[14]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[15]  S. Kaveri,et al.  Cryptic T cell epitopes in polymorphic immunoglobulin regions: Evidence for positive repertoire selection during fetal development , 1992, European journal of immunology.

[16]  E. Sercarz,et al.  Subjugation of dominant immunogenic determinants within a chimeric peptide , 1992, European journal of immunology.

[17]  M. Lai,et al.  T cell epitope selection: dominance may be determined by both affinity for major histocompatibility complex and stoichiometry of epitope , 1992, European journal of immunology.

[18]  J. Sidney,et al.  Effect of pH on MHC class II-peptide interactions. , 1992, Journal of immunology.

[19]  J. Berzofsky,et al.  Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes. , 1991, Journal of immunology.

[20]  N. Chirmule,et al.  Misinterpretation of results of cytokine bioassays. , 1991, Journal of immunological methods.

[21]  A. Steinberg,et al.  Theoretical and Experimental Approaches to Generalized Autoimmunity , 1990, Immunological reviews.

[22]  A. Rudensky,et al.  Immunoglobulin‐specific T‐B cell interaction III. B cell activation by immunoglobulinrecognizing T cell clones , 1990, European journal of immunology.

[23]  R. Coffman,et al.  Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.

[24]  A. Rudensky,et al.  Immunoglobulin‐specific T‐B cell interaction , 1989, European journal of immunology.

[25]  W. Paul,et al.  Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). , 1989, Journal of immunology.

[26]  E. Sercarz,et al.  Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. , 1987, Journal of immunology.

[27]  S. Datta,et al.  Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis , 1987, The Journal of experimental medicine.

[28]  P. Vandenabeele,et al.  A T cell clone which responds to interkeukin 2 but not to interleukin 4 , 1987, European journal of immunology.

[29]  R. Coffman,et al.  T-cell and mast cell lines respond to B-cell stimulatory factor 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Paul,et al.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1 , 1985, Nature.

[31]  W. Seaman,et al.  Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4 , 1985, The Journal of experimental medicine.

[32]  P. Marrack,et al.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition , 1981, The Journal of experimental medicine.

[33]  K. Ozato,et al.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. , 1980, Journal of immunology.

[34]  L. Herzenberg,et al.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. , 1978, Current topics in microbiology and immunology.